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Abstract- Intraventricularhemorrhage (IVH) is one of thecommon morbidities among preterm neonates. In 
thepresentstudy, we set out to evaluate the efficacy of two prophylactic modalities (ibuprofen and 
indomethacin prophylaxis) for prevention of IVH in our local setting. A prospective study was carried out in 
Akbar-Abadi Hospital, Tehran-Iran (2013-2014). Ninety-six preterm neonates who cared in closed incubator 
entered the study. Neonates randomly assigned into 3 groups; control, oral indomethacin (0.2 mg/kg 
indomethacin daily for 3 days) and oral ibuprofen (10,5,5 mg/kg ibuprofen every 24 hours during 3) 
administration. For all subjects brain sonography examination was performed in 3rd day, first, 2nd week of 
life and when infants reached to 36 and 42 weeks of postmenstrual age. The IVH prevalence and the 
effectiveness of the drugs among groups were statistically assessed. Of all 93 subjects; 14 cases had IVH 
(15.1%). IVH was significantly more frequent in the controls than in other groups (P=0.049). Prophylactic 
treatment could significantly decrease the incidence of grade 3 or 4 IVH in experimental groups (P=0.008). 
There were no significant differences between the three experimental groups with respect to theincidence of 
GI bleeding, Oliguria, renal dysfunction or NEC (P>0.05). This study demonstrates that low-dose 
prophylactic indomethacin and ibuprofen are equally associated with a reduction of IVH without any 
significant side effects like renal dysfunction, GI bleeding or NEC. 
© 2016 Tehran University of Medical Sciences. All rights reserved.  
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Approximately 15 million preterm births occur each 
year, and intraventricular hemorrhage (IVH) is one of 
thecommon related morbidities. In the US the 
prevalence of IVH among preterm infants is reported 
about 12 000 annually (1-4). 
 Low dose Indomethacin prophylaxis as an effective 
modality in declining the incidence of severe grades of 
IVH has confirmed by theprevious meta-analysis of 
randomized control trials (5). Its efficacy with thelack of 
side effects for theclosure of patent ductus arteriosus 
(PDA) is also well established (6). Ment et al. has 
indicated the role of Indomethacinadministration in 
decreasing theincidence of IVH in preterm infants (7). 
Mirza et al., also showed Indomethacin prophylaxis at 
the first 6 hours of life in females but not males was 
correlated with less IVH. Indomethacin by inhibition of 
prostaglandin synthesis and promotion of microvessel 
maturation may prevent ischemia related impaired 
cerebral perfusion in preterm infants (4).  
Despite some former studies of the role of 
Indomethacin prophylaxis, few studies have focused on 
the efficacy of Ibuprofenin declining the incidence of 
IVH (8-10). This non-steroidal anti-inflammatory drug 
enhances cerebral blood flow autoregulation and 
protects neurologic functions in animal model (10). 
Because of fewer side effects and less renal impairment, 
Ibuprofen as an alternative to indomethacin has been 
used for thetreatment of patent PDA worldwide (11). 
More than two third of all preterm birth (85%) was 
reported from Asian and African countries, and the 
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increasing number of preterm neonates in tertiary 
centers is notable (12,13). IVH as a common related 
complication not only increases the long life neonatal 
morbidities but also imposes a great financial burden on 
the healthcare system. We, therefore, set out to evaluate 
the efficacy of two prophylactic modalities (ibuprofen 
and indomethacin prophylaxis) for prevention of IVH in 
our local setting. 
 
Materials and Methods 
 
Participants 
A retrospective study was carried out in the neonatal 
intensive care unit (NICU) of Akbar-Abadi Hospital 
affiliated to Iran University of Medical Sciences 
(Tehran-Iran) in 2013-2014. Ninety-six preterm 
neonates in first 6-12 hours of life who cared in closed 
incubator entered the study. Inclusion criteria were 
preterm birth (<32 weeks), birth weight<1500 gram, no 
contraindication for administration of Ibuprofen or 
Indomethacin (Creatinine levels<1.2 mg/dl, platelet 
count>50000, no GI bleeding and necrotising 
enterocolitis) and parents' informed consents. Preterm 
infants with gestational age<26 weeks, severe birth 
asphyxia, chromosomal and congenital anomalies were 
excluded. Laboratory tests including CBC, BUN, and 
Creatinine levels were performed for all subjects. 
Participants' demographic data including sex, age, 
gestational age, weight, and first and five-minuteApgar 
scores were recorded in some checklists.  
 
Intervention  
Preterm infants who met the inclusion criteria 
entered the study. Neonates randomly (simple 
randomization) assigned into 3 groups; control, oral 
indomethacin and oral ibuprofen administration. 
Participants in the control group received only 
standard care. Newborns in thesecond group received 
0.2 mg/kg indomethacin daily for 3 days. Indomethacin 
suspension was prepared based on Ora-Base®   و Ora-
Sweet® (table 1). 
 
Table 1. Preparation of 
indomethacin suspension 
Ingredients % (W/V) 
○Avicel RC 591 
○Citric acid anhydrous 
○Glycerin 












Up to 100% 
 
Subjects in thethird group received 10,5,5 mg/kg 
ibuprofen every 24 hours during 3 consecutive days. 
Each group's intervention was started during in 
physiological stable state. All infants were monitored for 
potential drug side effects, and intervention was 
immediately stopped if any infant's complications such 
as thrombocytopenia, IVH (>grade 2), GI or pulmonary 
bleeding, Creatinine>1.2 mg/dl, Na<120 mEq/L, urinary 
output<0.5ml/hour happened. 
IVH grades (1-4) were determined based on papileet 
al., classification (14). For all subjects brain sonography 
examination was performed in 3rd day, first, 2nd week 
of life and when infants reached to 36 and 42 weeks of 
postmenstrual age (PMA; gestational age plus the time 
elapsed after Birth). Blood test including CBC, urea, 
Creatinine; electrolytes was carried out daily in first 4 
days. Urinary output was measured and recorded in 
thechart. All gathered data in both experimental and 
control groups were recorded in some checklists.  
The primary outcome was IVH prevalence and the 
effectiveness of the drugs in 2 experimental groups. 
Secondary outcome included determination of 
prevalence necrotising enterocolitis, renal failure, 
hemorrhagic episodes and infant demise. 
 
Statistical analysis 
All recorded data were analyzed and compared in 
three groups statistically by software package SPSS 
version 18. Frequency was reported by mean+SD. 
ANOVA, Fisher exact test, Chi-square and student t-test 
were used to analyze the correlations between variables. 
The level of significance was considered asP<0.05. With 
the proposed sample size of 93, the study had a power of 
70% and an alpha error of 0.05. 
Our study was taken from the medical student thesis 
with ID 1058 and approved by the institutional review 
board of Iran University of Medical Sciences according 
to Helsinki declaration. Participants' parents gave 
informed consent before entering the study. Our 
gathered data were confidential, and no extra cost was 




Ninety-three neonates; 31 in each group entered the 
study. Mean age and weight were 30.27±1.7 weeks and 
1448.4±331.7 gram. Forty-five cases were female. Mean 
hospitalization period was 23.1±17days. Of 93 subjects; 
IVH and NEC were seen in 14 (15.1%) and 8 (8.6%) 
neonates, respectively. Nine cases (6.5%) had GI 
bleeding, and five neonates died during hospitalization. 
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Seventy-five infants (80.6%) had received 
betamethasone administration prior birth. Demographic 
data of 3 groups are shown in table 2. 
 
Table 2. Neonatal demographic data 
variables Control indomethacin ibuprofen P-value 
Mean age (weeks) 1.8±30.1 8.6±30.3 1.7±30.3 0.06 
Mean birth weight (gram) 325±1342.9 287±1459 257±1542 0.83 
Sex (female) 54.8(%17) 54.8 (%17) 45.2 (%14) 0.67 
IVH (n %) 10(32.3) 2(6.5%) 2(6.5%) 0.005 
 
 
Statistical analysis showed that IVH was 
significantly more frequent in the controls than in other 
groups (10 Vs. 2 and 2; P=.049).  Prophylactic treatment 
could significantly decrease the incidence of grade 3 or 
4 IVH in experimental groups (P=.008); of 7 cases with 
grade 3 and 4 IVH, 6 newborns were in control and one 
in indomethacin group. Results did not depict any 
significant differences between indomethacin and 
ibuprofen administration regarding the incidence of 
IVH. There were no significant correlations between 
incidence of IVH and  the demographic variables 
including gestational age, birth weight, mortality rate, 
low first and five-minuteApgar scores, betamethasone 
administration prior birth and hospitalization period 
(P>.05). There were no significant differences between 
the three experimental groups with respect to 
theincidence of GI bleeding or NEC (P.value>.05). 
Oliguria or renal dysfunction was not observed in our 
population study. Details are shown in table 3.  
 
Table 3. Incidence of complications according to treatment group 





In first three days 4 )9.7(%3  )3.2(%1) -- 0.226 
1 --  )3.2(%1) --
In first week 
4 )3.2(%1  )3.2(%1) -- 
0.65 
3 )3.2(%1  -- --
1 )3.2(%1  )3.2(%1  -- 
In second week 
4 )12.9(%4  )3.2(%1  -- 
0.116 3 
)3.2(%1  --  -- 
2 --  )3.2(%1  -- 
1 )9.7(%3  --  )6.5(%2  
Age (week) 
26-28 )16.1(%5  )16.1(%5  )12.9(%4  
0.52 
28-30 )45.2(%14  )22.6(%7  )28.7(%15  
30-32 )35.5(%11 )58.1(%18  )48.4(%15  
>32 )3.2(%1  )3.2(%1  --  
Birth weight (gr) 
500-1000 )16.1(%5  )6.5(%2  )6.5(%2  
.0.52 1000-1500 )51.6(%16  )48.4(%15  )45.2(%14 
1500-2000 )32.3(%10  )45.2(%14 )48.4(%15  
PDA )35.5(%11  )25.8(%8  )25.8(%8  0.62 
NEC )6.5(%2  )9.7(%3  )9.7(%3  0.87 
GI bleeding )3.2(%1  )12.9(%4  )3.2(%1  0.20 
mortality )6.5(%2  )3.2(%1  )6.5(%2  0.80 
Hospitalization (day) 25.3±13.9  21.9±17.9  32.1±18.1  0.69 
 
 
Of 8 cases with NEC, 2 cases underwent surgery, 5 
received medical treatment, and a neonate died. No 
significant differences were observed among 3 groups 
regarding to surgical or medical treatment (Table 4). 
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Table 4. ECN treatment among groups 
 Control Indomethacin Ibuprofen 
No NEC treatment 0 1 0 0.00% 33.30% 0.00% 
Surgery 0 1 1 0.00% 33.30% 33.30% 





There are many publications that provide valuable 
statistic data for management ofIVH in Iran (15-17), but 
to our knowledge, this study is the first investigation 
which assessed the effectiveness of indomethacin and 
ibuprofen in IVH prophylaxis.  
Based on the results prophylactic indomethacin or 
ibuprofen administered at first 6-12 hours of life was 
significantly related with alower incidence of IVH. In 
consistentwith our result, Ment et al. showed the 
positive role of Indomethacinadministration on 
theincidence of IVH in preterm infants (7). Garner et al., 
demonstrated a lower IVH incidence with 9% increase 
in fractional cerebral oxygen extraction 
withindomethacinprophylaxis in 27 VLBW neonates 
(18). However, the best time for prophylactic 
administration has not been established. Mirza et al., in 
2 different studies in 2008 and 2016 showed that in 
contrast indomethacin administration before 6 hours, 
prophylaxis at 6-12 hours of age significantly reduced 
the incidence of grade 3-4 IVH in preterm infants (4,19). 
On the other hand,Schmidt indicated that receiving 
indomethacin immediately after birth caused asignificant 
decline in the frequency of severe peri-intraventricular 
hemorrhage (odds ratio, 0.6; P=0.02) (20). 
The incidence of grade 3 and 4 IVH in experimental 
groups was significantly lower than thecontrol group 
(3.2 Vs 19.4%) (P=.008). In accordance with our results 
Schmidt et al. revealed that the use of indomethacin 
prophylaxis had declined the incidence of severe peri 
and intraventricular hemorrhage in extremely-low-birth-
weight neonates (20). 
We could not depict any significant differences 
between indomethacin and ibuprofen groups with regard 
to the incidence of IVH. In contrary to our result Aranda 
et al., showed despite theefficacy of ibuprofen on 
theclosure of patent ductus arteriosus, it was not 
effective as indomethacin with respect to IVH 
prevention (8). 
The results did not demonstrate any significant 
differences between two experimental groups with 
respect to adverse effects such as GI bleeding, NEC, 
Oliguria or renal dysfunction. On the other hand 
Johnston et al., pointed to greater side effects 
(spontaneous intestinal perforation, NEC, oliguria, and 
renal failure) with indomethacin than ibuprofen that may 
relate to themode of administration, dosage, prolonged 
versus short course and continuous infusion versus 
intermittent bolus (21).  
Our study had some limitation; the main limitation 
was the small sample size. Moreover, we did not 
consider the different dosage, timing of administration 
or other prevention trials such as Activated factor VII, 
Phenobarbital that absolutely may provide more 
beneficial data.  
In treatment for IVH with multifactorial etiology, 
responses to interventions should be considered (22). 
This study demonstrates that low-dose prophylactic 
indomethacin and ibuprofen are equally associated with 
a reduction of IVH without any significant side effects 
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